Understanding Prior Authorization Timelines to Prevent Care Interruptions

Overview

Prior authorization requirements can cause significant delays in medication access, as illustrated by a patient with multiple sclerosis who experienced a two-week interruption in her GLP-1 weight loss medication. Lack of clear communication about authorization expiration and complex insurer processes contribute to these challenges.

Background

Prior authorization is a process insurers use to approve certain costly or specialized treatments before coverage is granted, aiming to ensure medical necessity and control costs. However, this process can be opaque and burdensome for both patients and physicians, often leading to delays in care. Patients with chronic illnesses, like multiple sclerosis, may be particularly vulnerable to disruptions when prior authorizations expire without timely notification.

Data Highlights

In one case, a patient was off her medication for two weeks due to an expired prior authorization and a subsequent 7 to 10 business day approval process. A recent poll found that 1 in 3 insured adults consider prior authorizations a major burden to accessing healthcare. Federal regulations require urgent prior authorization requests for employer-based plans to be decided within 72 hours, but these rules do not apply to medications.

Key Findings

• Prior authorizations are commonly required for expensive medications, such as GLP-1 weight loss drugs, leading to increased scrutiny and delays.
• Patients often do not receive clear communication when prior authorizations expire, resulting in unexpected treatment interruptions.
• The prior authorization process can take 7 to 10 business days, during which patients may be without necessary medication.
• Expedited reviews are possible but require the physician to initiate the request, and criteria for urgency are not well defined.
• Insurance policies and prior authorization durations vary widely, complicating patient and provider navigation.
• Standardizing prior authorization procedures could reduce administrative burdens and prevent care disruptions.

Clinical Implications

Clinicians should proactively monitor prior authorization expiration dates and communicate with patients to prevent treatment gaps. Educating patients about the need for timely renewal and the possibility of expedited reviews can mitigate adverse health effects. Advocacy for standardized and transparent prior authorization processes may improve care continuity.

Conclusion

Prior authorization processes, while intended to ensure appropriate care and control costs, can inadvertently disrupt treatment, especially for chronic conditions. Improved communication, timely renewals, and policy reforms are needed to prevent avoidable interruptions in patient care.

References

1. Oona Zenda/KFF Health News 2024 -- Understanding the Timelines of Prior Authorization to Prevent Interruptions in Care